<DOC>
	<DOCNO>NCT02798861</DOCNO>
	<brief_summary>The primary aim determine accuracy CAP quantification liver steatosis use liver biopsy reference . Secondarily , investigator correlate transient elastography ( TE ) CAP result , analyze possible association CAP/TE post-liver transplant ( LT ) clinical outcome , evaluate change CAP LT . The study aim include many donor need achieve 100 transplant liver allograft .</brief_summary>
	<brief_title>Controlled Attenuation Parameter ( CAP ) Liver Allografts</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<criteria>Inclusion criterion Liver Recipient Men woman , Age 18years old 80years old inclusive Inclusion criterion Liver Donor Valid TE Fibroscan 530/502 , define : At least 10 valid measurement IQR/Median stiffness value &lt; 30 % ( case &gt; 7.1 kPa ) Exclusion criterion Liver Recipient Patient undergo liver transplantation Exclusion criterion Liver Donor Donation circulatory death ( DCD ) Donor receive vasoactive amine ALT AST &gt; 300 No liver biopsy obtain organ procurement process</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>